Tachibana Atsushi, Santoso Michelle R, Mahmoudi Morteza, Shukla Praveen, Wang Lei, Bennett Mihoko, Goldstone Andrew B, Wang Mouer, Fukushi Masahiro, Ebert Antje D, Woo Y Joseph, Rulifson Eric, Yang Phillip C
From the Division of Cardiovascular Medicine (A.T., M.R.S., M.M., P.S., L.W., M.W., A.D.E., E.R., P.C.Y.), Division of Neonatal and Developmental Medicine (M.B.), and Department of Cardiothoracic Surgery (A.B.G., Y.J.W.), Stanford University, CA; Department of Radiological Sciences, Tokyo Metropolitan University, Japan (A.T., M.F.); Department of Critical Care Medicine, 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine, China (L.W.); Department of Cardiology and Pneumonology, Göttingen University Medical Center, Germany (A.D.E.); and German Center for Cardiovascular Research, Partner Site Göttingen, Germany (A.D.E.).
Circ Res. 2017 Sep 1;121(6):e22-e36. doi: 10.1161/CIRCRESAHA.117.310803. Epub 2017 Jul 25.
Cardiac myocytes derived from pluripotent stem cells have demonstrated the potential to mitigate damage of the infarcted myocardium and improve left ventricular ejection fraction. However, the mechanism underlying the functional benefit is unclear.
To evaluate whether the transplantation of cardiac-lineage differentiated derivatives enhance myocardial viability and restore left ventricular ejection fraction more effectively than undifferentiated pluripotent stem cells after a myocardial injury. Herein, we utilize novel multimodality evaluation of human embryonic stem cells (hESCs), hESC-derived cardiac myocytes (hCMs), human induced pluripotent stem cells (iPSCs), and iPSC-derived cardiac myocytes (iCMs) in a murine myocardial injury model.
Permanent ligation of the left anterior descending coronary artery was induced in immunosuppressed mice. Intramyocardial injection was performed with (1) hESCs (n=9), (2) iPSCs (n=8), (3) hCMs (n=9), (4) iCMs (n=14), and (5) PBS control (n=10). Left ventricular ejection fraction and myocardial viability, measured by cardiac magnetic resonance imaging and manganese-enhanced magnetic resonance imaging, respectively, was significantly improved in hCM- and iCM-treated mice compared with pluripotent stem cell- or control-treated mice. Bioluminescence imaging revealed limited cell engraftment in all treated groups, suggesting that the cell secretions may underlie the repair mechanism. To determine the paracrine effects of the transplanted cells, cytokines from supernatants from all groups were assessed in vitro. Gene expression and immunohistochemistry analyses of the murine myocardium demonstrated significant upregulation of the promigratory, proangiogenic, and antiapoptotic targets in groups treated with cardiac lineage cells compared with pluripotent stem cell and control groups.
This study demonstrates that the cardiac phenotype of hCMs and iCMs salvages the injured myocardium effectively than undifferentiated stem cells through their differential paracrine effects.
源自多能干细胞的心肌细胞已显示出减轻梗死心肌损伤并提高左心室射血分数的潜力。然而,功能益处背后的机制尚不清楚。
评估心肌损伤后,与未分化的多能干细胞相比,移植心脏谱系分化衍生物是否能更有效地增强心肌活力并恢复左心室射血分数。在此,我们在小鼠心肌损伤模型中对人胚胎干细胞(hESCs)、hESC衍生的心肌细胞(hCMs)、人诱导多能干细胞(iPSCs)和iPSC衍生的心肌细胞(iCMs)进行了新型多模态评估。
在免疫抑制小鼠中诱导左前降支冠状动脉永久性结扎。进行心肌内注射,注射对象为:(1)hESCs(n = 9),(2)iPSCs(n = 8),(3)hCMs(n = 9),(4)iCMs(n = 14),以及(5)PBS对照组(n = 10)。与多能干细胞或对照组处理的小鼠相比,hCM和iCM处理的小鼠的左心室射血分数和心肌活力(分别通过心脏磁共振成像和锰增强磁共振成像测量)显著改善。生物发光成像显示所有处理组中的细胞植入有限,这表明细胞分泌物可能是修复机制的基础。为了确定移植细胞的旁分泌作用,在体外评估了所有组上清液中的细胞因子。与多能干细胞和对照组相比,对小鼠心肌进行的基因表达和免疫组织化学分析表明,心脏谱系细胞处理组中促迁移、促血管生成和抗凋亡靶点的表达显著上调。
本研究表明,hCMs和iCMs的心脏表型通过其不同的旁分泌作用比未分化干细胞更有效地挽救受损心肌。